Clinical trial
Study Evaluating DVS-233 SR to Treat Vasomotor Systems Associated With Menopause
NCT00256685 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00256685 |
|---|---|
| Title | Study Evaluating DVS-233 SR to Treat Vasomotor Systems Associated With Menopause |
| Official title | A Double-Blind, Randomized, Placebo-Controlled Efficacy and Safety Study of DVS-233 SR for Treatment of Vasomotor Symptoms Associated With Menopause |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Menopause, Hot Flashes, Sleep Disorders |
| Intervention type | Drug |
| Interventions | DVS-233 SR |
| Enrollment | 568 |
| Start date | Sep 1, 2004 |
| Completion | Jul 1, 2005 |
| First posted | Nov 21, 2005 |
| Last update posted | May 19, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: